Colorectal cancer data study at Xijing Hospital
Part of Cancer, Digestive system clinical trials.
This study collects and reviews medical records from patients diagnosed with colorectal adenocarcinoma at Xijing Hospital between 2013 and 2023. The goal is to build a dataset for future research—no new treatments or procedures are being tested.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have colorectal adenocarcinoma (a type of colon or rectal cancer).
- You must have been diagnosed between 2013 and 2023.
- You must have complete medical records and pathology reports from Xijing Hospital.
- You cannot have a different type of colorectal cancer (like sarcoma or lymphoma).
- You cannot have a colorectal tumor caused by another cancer spreading from elsewhere.
- You cannot have a benign (non-cancerous) colorectal growth or recurrent cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information from people with newly diagnosed colon or rectal cancer, to better understand the disease and support future research. It may help you and others by improving how colorectal cancer is studied and potentially treated over time.
This retrospective study uses existing colorectal cancer imaging and/or preserved tissue samples to support more precise (personalized) research. It may help researchers better understand colorectal cancer over time, but it does not involve new treatment.
This study is testing a new way to help doctors better detect colorectal cancer by building a model that uses your risk factors and colonoscopy results. If you join, you'll answer a questionnaire and let the researchers use your routine colonoscopy and medical data to improve this model.
This study follows people with colorectal cancer of any stage to learn more about their care and outcomes. It may help researchers improve treatments for future patients.
This study recruits adults in Yangzhou to help screen for colorectal cancer risk using a lab test based on “methylation,” a way cells can carry disease-related changes. You would mainly complete a risk questionnaire and phone follow-ups, and agree to share any cancer diagnosis information during the study.
This study collects clinical and lab information from people who have surgery for colon cancer (or certain precancer growths) and related spread to organs. It may help researchers better understand colon cancer and improve future care, but it is not a new medication trial.
Hear when a new Prognostic Cancer Model trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.